Skip to main content

Medical Treatment of Cardiovascular Disease in the Elderly

  • Chapter
Cardiovascular Disease in the Elderly

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 76))

  • 43 Accesses

Abstract

Elderly patients constitute a group in whom diseases are “creeping up.” These diseases may not be cardiovascular but influence the general level of activity of the patient and the general feeling of health or ill-health. Therefore, the patient may apparently present with a cardiovascular problem when the real diagnosis lies elsewhere.

Unique features of illness in the elderly may interfere with effective drug therapy more than changed pharmacokinetics.

OUSLANDER, 1981 [1]

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ouslander JG. Drug therapy in the elderly. Ann Intern Med 95:711–722, 1981.

    Article  PubMed  CAS  Google Scholar 

  2. Amery A, Brixko P, Clement D, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1:1349–1354, 1985.

    Article  PubMed  CAS  Google Scholar 

  3. Dall JLC. Maintenance digoxin in elderly patients. Br Med J 2:705–706, 1070.

    Article  Google Scholar 

  4. Causack, B, Kelly J, O’Malley K, et al. Digoxin in the elderly: Pharmacokinetic consequences of old age. Clin Pharmacol Ther 25(6):772–776, 1979.

    Google Scholar 

  5. Ewy GA, Kapadia GG, and Yao L. Digoxin metabolism in the elderly. Circulation 39:449–453, 1969.

    Article  PubMed  CAS  Google Scholar 

  6. Berman W Jr and Musselman J. The relationship of age to the metabolism and protein binding of digoxin in sheep. J Pharmacol Exp Ther 208(2):263–266, 1979.

    PubMed  CAS  Google Scholar 

  7. Gerstenblith G, Spurgeon HA, Froehlich JP, et al. Diminished inotropic responsiveness to ouabain in aged rat myocardium. Circ Res 44(4):517–523, 1979.

    Article  PubMed  CAS  Google Scholar 

  8. Guarnieri T, Spurgeon H, Froehlich JP, et al. Diminished inotropic responses but unaltered toxicity to acetylsbrophanthidin in the senescent beagle. Circulation 60(7):1548–1554, 1979.

    Article  PubMed  CAS  Google Scholar 

  9. Whiting B, Wandless I, Summer DJ, and Goldberg A. Computer-assisted review of digoxin therapy in the elderly. Br Heart J 40(1):8–13, 1978.

    Article  PubMed  CAS  Google Scholar 

  10. Castleden et al. Br J Clin Pharmacol 2:303, 1975.

    Article  PubMed  CAS  Google Scholar 

  11. Vestal RE, Wood AJ, and Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Phar Ther 26(2):181–186, 1979.

    CAS  Google Scholar 

  12. Schocken DD and Roth GS. Reduced beta-adrenergic receptor concentrations in ageing man. Nature 267 (5614):856–858, 1977.

    Article  PubMed  CAS  Google Scholar 

  13. Yin FCP, Spurgeon HA, Raizes GS, et al. Age-associated decrease in chronotropic response to isoproterenol (abstract). Circulation 54 11:167, 1976.

    Google Scholar 

  14. Cokkinos DV, Tsartsalis GD, Heimonas ET, and Gardikas CD. Comparison of the inotropic action of digitalis and isoproterenol in younger and older individuals. Am Heart J 100(6 Pt 1):802–806, 1980.

    Article  PubMed  CAS  Google Scholar 

  15. Guarnieri T, Filburn CR, Zitnik G, et al. Contractile and biochemical correlates of beta-adrenergic stimulation of the aged heart. Am J Physiol 239(4):H501-H508, 1980.

    Google Scholar 

  16. Nation RI, Triggs EJ, and Selig M. Lignocaine kinetics in cardiac patients and aged subjects. Br J Clin Pharmacol 4(4):439–448, 1977.

    Article  PubMed  CAS  Google Scholar 

  17. Reidenberg MM, Camacho M, Kluger J, and Drayer DE. Aging and renal clearance of procainamide and acetylprocainamide. Clin Pharmacol Ther 28(6):732–735, 1980.

    Article  PubMed  CAS  Google Scholar 

  18. Ochs HR, Greenblatt DJ, Woo E, and Smith TW. Reduced quinidine clearance in eldery persons. Am J Cardiol 42(3):481–485, 1978.

    Article  PubMed  CAS  Google Scholar 

  19. Shepherd AM, Hewick DS, Moreland TA, and Stevenson IH. Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol 4:315–320, 1977.

    Article  PubMed  CAS  Google Scholar 

  20. Ashraf N, Locksley R, and Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 70:1163–1168, 1981.

    Article  PubMed  CAS  Google Scholar 

  21. Epstein M and Hollenberg NK. Age as determinant of renal sodium conservation in normal man. J Lab Clin Med 87:411–417, 1976.

    PubMed  CAS  Google Scholar 

  22. Zacharias FJ and Cruickshank JM. Treating the elderly hypertensive. Acta Therap 5:179–192, 1979.

    Google Scholar 

  23. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Brit. Med. J. 293:1145–1148, 1986.

    Article  CAS  Google Scholar 

  24. Bühler FR, Bolli P, Erne P, et al. Position of calcium antagonists in antihypertensive therapy. J Cardiovasc Pharmacol 7 (suppl 4): 521-S27, 1985.

    Google Scholar 

  25. Ben-Ishay D, Leibel B, and Stessman J. Calcium channel blockers in the management of hypertension in the elderly. Am J Med 81 (Suppl 6A):30–34, 1986.

    Article  PubMed  CAS  Google Scholar 

  26. Harris R. The old heart. In G Bourne (ed), Hearts and Heart-like Organs, Vol. 3. New York: Academic Press, 1980, pp 159–188.

    Google Scholar 

  27. Chaudhry AY, Bing RF, Castelden CM, et al. The effect of ageing on the response to frusemide in normal subjects. Eur J Clin Pharmacol 27:303–306, 1984.

    Article  PubMed  CAS  Google Scholar 

  28. Andreasen F, Hansen U, Husted SE, et al. The influence of age on renal and extrarenal effects of frusemide. Brit J Clin Pharmac 18:65–74, 1984.

    Article  CAS  Google Scholar 

  29. Hamdy RC. Diuretic Therapy in the Older Patient. Philadelphia: Smith, Kline and French, 1978, pp 47–50.

    Google Scholar 

  30. Lye M. Body potassium content and capacity of elderly individuals with and without cardiac failure. Cardiovasc Res 16:22–25, 1982.

    Article  PubMed  CAS  Google Scholar 

  31. Gersh BJ, Kronmal RA, Schaff HV, et al. Long-term (5 year) results of coronary bypass surgery in patients 65 years old or older: A report from the Coronary Artery Surgery Study. Circulation 68 (Suppl II): 11–190–11–199, 1983.

    Google Scholar 

  32. Knapp WS, Douglas JS, Craver JM, et al. Efficacy of coronary bypass grafting in elderly patients with coronary artery disease. Am J Cardiol 47:923–930, 1981.

    Article  PubMed  CAS  Google Scholar 

  33. Wintzen AR, Tijssen JGP, deVries WA, et al. Risk of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Second report of the sixty plus reinfarction study research group. Lancet 1:64–68, 1982.

    Google Scholar 

  34. Hawkins CM, Richardson DW, Vokonas PS. Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience. Circulation 67 (Suppl I):I-94-I97, 1983.

    Google Scholar 

  35. Gundersen, T. Abrahamsen AM, Kjekshus J, and Ronnevik PK. Timolol-related reduction in mortality and reinfarction in patients aged 65–75 years surviving acute myocardial infarction. Circulation 66:1179–1184, 1982.

    Article  PubMed  CAS  Google Scholar 

  36. Olsson G, Rehnqvist N, Sjogren A, et al. Long-term treatment with metoprolol after myocardial infarction: Effect on 3 year mortality and morbidity. J Am Coll Cardiol 5:1428–1437, 1985.

    Article  PubMed  CAS  Google Scholar 

  37. Schocken DD, Blumenthal JA, Port S. et al. Physical conditioning and left ventricular performance in the elderly: Assessment by radionuclide angiocardiography. Am J Cardiol 52:359–364, 1983.

    Article  PubMed  CAS  Google Scholar 

  38. The Anturane Reinfarction Trial Research Group. Sulfinpyrazone in the prevention of sudden death after myocardial infarction. N Engl J Med 302(5):250–256, 1980.

    Article  Google Scholar 

  39. Anturane Reinfarction Italian Study. Sulphinpyrazone in postmyocardial infarction. Lancet 1:237–242, 1982.

    Google Scholar 

  40. Aspirin Myocardial Infarction Study Research Group. A randomized controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 243:661–669, 1980.

    Article  Google Scholar 

  41. Persantine-Aspirin Reinfarction Study Research Group. Persantine and aspirin in coronary heart disease. Circulation 62:449–461, 1980.

    Article  Google Scholar 

  42. Murphy ES, Lawson RM, Starr A, et al. Severe aortic stenosis in patients 60 yeras of age and older: left ventricular function and 10-year survival after valve replacement. Circulation 64 (Suppl II):II-184–II–188, 1981.

    Google Scholar 

  43. Commerfold PJ, Curcio A, Albanese M, and Beck W. Aortic valve replacement in the elderly. South Afr Med J 59:975–976, 1981.

    Google Scholar 

  44. De Bono AHB, English TAH, and Milstein BB. Heart valve replacement in the elderly. Br Med J 2:917–919, 1978.

    Article  PubMed  Google Scholar 

  45. Waller BF and Roberts WC. Cardiovascular disease in the very elderly. Analysis of 40 necropsy patients aged 90 years or over. Am J Cardiol 51:403–421, 1983.

    Article  PubMed  CAS  Google Scholar 

  46. Kolibash AJ, Bush CA, Fotana MB, et al. Mitral valve prolapse syndrome: Analysis of 62 patients aged 60 years and older. Am J Cardiol 52:534–539, 1983.

    Article  PubMed  CAS  Google Scholar 

  47. Templeton GH, Platt MR, Willerson JT, and Weisfeldt MI. Influence of aging on left ventricular hemodynamics and stiffness in beagles. Circ Res 44:189–194, 1979.

    Article  PubMed  CAS  Google Scholar 

  48. Camm AJ, Evans KE, Ward DE, and Martin A. The rhythm of the heart in active elderly subjects. Am Heart J 99:598–603, 1980.

    Article  PubMed  CAS  Google Scholar 

  49. Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 229:53–59, 1978.

    Article  Google Scholar 

  50. Fields WS, Lemak NA, Frankowski KF, et al. Controlled trial of aspirin in cerebral Uchemia. Circulation 62 (Suppl V):V90—V96, 1980.

    Google Scholar 

Suggested Readings

  • Anderson GJ. Clinical clues to digitalis toxicity. Geriatrics 35(6):57–65, 1980.

    PubMed  CAS  Google Scholar 

  • Harris R. The Management of Geriatric Cardiovascular Disease. Philadelphia: Lippincott, 1970.

    Google Scholar 

  • Lee PV. Drug therapy in the elderly: The clinically pharmacology of aging. Clin Exper Res 2:39–42.

    Google Scholar 

  • Lowenthal DT and Affrime MB. Cardiovascular drugs for the geriatric patient. Cardiology 36:65–74, 1981.

    CAS  Google Scholar 

  • Mitenko PA, Comfort A, and Crooks J (eds). Drugs and the elderly. Proceedings of a symposium. J Chronic Dis 36(1), 1983.

    Google Scholar 

  • O’Hanrahan M and O’Malley K. Compliance with drug treatment. Br Med J 283:298–300, 1981.

    Article  Google Scholar 

  • Swift CG. Clinical pharmacology in the elderly. Scott Med J 24:221–225, 1979.

    PubMed  CAS  Google Scholar 

  • Unverferth DV, Magorien RD, and Leier CV. Drug regimens for congestive heart failure. Geriatrics 35(7):26–33, 1980.

    PubMed  CAS  Google Scholar 

  • Vestal RE. Drug use in the elderly: A review of problems and special considerations. Drugs 16:358–382, 1978.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Opie, L.H., Mabin, T.A. (1987). Medical Treatment of Cardiovascular Disease in the Elderly. In: Messerli, F.H. (eds) Cardiovascular Disease in the Elderly. Developments in Cardiovascular Medicine, vol 76. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-9925-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-9925-4_18

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-9927-8

  • Online ISBN: 978-1-4684-9925-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics